查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589562

利尿剂市场：按药物类型、分销管道、给药途径、应用划分 - 全球预测 2025-2030

Diuretics Drugs Market by Drug Type (Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics), Distribution Channel (Drug Stores, Hospital Pharmacies, Online Pharmacies), Route of Administration, Applications - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年利尿剂市值为11.9亿美元，预计2024年将达到12.9亿美元，复合年增长率为8.54%，预计到2030年将达到21.2亿美元。

利尿剂通常被称为水丸，是一种旨在增加肾臟排出水和盐的药物，对于治疗高血压、心臟衰竭和水肿相关疾病等多种疾病至关重要。对利尿剂的需求主要源自于其缓解液体储存和降低血压的能力，从而降低中风和心臟病发作的风险。利尿剂的用途涵盖医疗和临床环境，用于治疗肾功能障碍和预防因积液过多而引起的併发症。最终用途范围涵盖医院、诊所、门诊病人设施和家庭医疗保健环境。由于心血管疾病盛行率上升、老年人口增加以及生活方式相关疾病发生率增加，利尿剂市场预计将成长。关键的成长要素包括联合治疗，该疗法将利尿剂与其他抗高血压药物结合以优化治疗效果。特别是在长期高血压治疗中，有很大机会开发创新配方，以提高患者的依从性并最大限度地减少副作用。个人化医疗的推动也开启了基于基因分析客製化利尿疗法的可能性。然而，该市场存在局限性，例如电解质不平衡等潜在副作用以及医药品认证过程中的监管障碍。此外，副作用较少的替代疗法的出现也是一个竞争挑战。精准医学和先进利尿剂的合成领域具有创新潜力，可提高治疗效果并减少副作用併发症。製药公司和生技公司之间的合作可以带来药物传输系统的突破。在持续研究和消费者对更安全、更有效的治疗解决方案的需求的推动下，利尿剂市场仍然充满活力，这使得持续创新和策略联盟至关重要。

主要市场统计
基准年[2023] 11.9亿美元
预测年份 [2024] 12.9亿美元
预测年份 [2030] 21.2亿美元
复合年增长率（%） 8.54%

市场动态：揭示快速发展的利尿剂市场的关键市场洞察

供需的动态交互作用正在改变利尿剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 肾臟和肾臟疾病盛行率上升
    • 世界老年人口的增加
    • 高血压和高血压治疗的采用率增加
  • 市场限制因素
    • 与患者不良反应相关的风险
  • 市场机会
    • 开发和引进新治疗方法
    • 政府对保健药品生产的扶持措施
  • 市场挑战
    • 监管机构的严格监管和合规

波特驾驭利尿剂市场的五种策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解利尿剂市场的外部影响

外部宏观环境因素对利尿药市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解利尿剂市场的竞争状况

利尿剂市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵利尿剂市场供应商的绩效评估

FPNV定位矩阵是评估利尿剂市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了利尿药市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对利尿药市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 肾臟疾病盛行率增加
      • 世界各地老年人口不断增长
      • 高血压治疗的采用率增加
    • 抑制因素
      • 对患者产生不良影响的风险
    • 机会
      • 开发和引进新治疗方法
      • 政府对保健药品生产的扶持措施
    • 任务
      • 监管机构的严格监管和合规
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章：按类型分類的利尿剂市场药物

  • 保钙利尿剂
  • 碳酸酐酶抑制剂
  • 袢利尿剂
  • 低天花板利尿剂
  • 渗透性利尿剂
  • 保钾利尿剂
  • 噻嗪类利尿剂药房

第七章 利尿剂市场：依分销管道

  • 药局
  • 医院药房
  • 网路药房
  • 零售药房

第八章 利尿剂市场：依给药途径

  • 静脉
  • 口服

第九章 利尿剂市场：依应用分类

  • 尿崩症
  • 浮肿
  • 高钙尿症
  • 高血压

第10章美洲利尿剂市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太利尿剂市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲利尿剂市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Amneal Pharmaceuticals LLC
  • Centaur Pharmaceuticals Pvt Ltd
  • Hikma Pharmaceuticals Inc.
  • Merck & Co., Inc.
  • Novartis International AG
  • Perrigo Pharmaceuticals Company
  • Sanofi SA
  • Zydus Lifesciences Limited
Product Code: MRR-4103B31E0594

The Diuretics Drugs Market was valued at USD 1.19 billion in 2023, expected to reach USD 1.29 billion in 2024, and is projected to grow at a CAGR of 8.54%, to USD 2.12 billion by 2030.

Diuretics drugs, often called water pills, are medications designed to increase the excretion of water and salts through the kidneys, making them a crucial component in managing various medical conditions, such as hypertension, heart failure, and edema-linked disorders. The necessity for diuretics primarily stems from their ability to alleviate fluid retention and lower blood pressure, thereby reducing the risks of strokes and heart attacks. Their application spans across medical and clinical environments for treating renal dysfunctions and preventing complications from excessive fluid buildup. The end-use scope covers hospitals, clinics, outpatient facilities, and home healthcare settings. The diuretics drug market is poised for growth due to the rising prevalence of cardiovascular disorders, increasing geriatric populations, and the expanding incidence of lifestyle-associated ailments. Key growth influencers include advancements in combination therapies integrating diuretics with other antihypertensives, optimizing treatment efficacy. Noteworthy opportunities lie in developing innovative formulations that improve patient adherence and minimize side effects, particularly for long-term hypertensive treatment. The push towards personalized medicine also opens possibilities for tailoring diuretic therapies based on genetic profiling. However, the market encounters limitations such as potential side effects like electrolyte imbalance and regulatory hurdles pertaining to drug approval processes. Furthermore, the emergence of alternative therapies that promise fewer adverse effects poses a competitive challenge. Innovation can thrive in the fields of precision medicine and in the synthesis of advanced diuretics that have fewer side complications while enhancing therapeutic effectiveness. Partnerships between pharmaceutical companies and biotechnology firms can lead to breakthroughs in drug delivery systems. The diuretics drug market remains dynamic, driven by ongoing research and consumer demand for safer and more effective therapeutic solutions, underscoring the imperative for continuous innovation and strategic collaborations.

KEY MARKET STATISTICS
Base Year [2023] USD 1.19 billion
Estimated Year [2024] USD 1.29 billion
Forecast Year [2030] USD 2.12 billion
CAGR (%) 8.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diuretics Drugs Market

The Diuretics Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of renal and kidney disorders
    • Growing geriatric populace globally
    • Increasing adoption to treat high blood pressure and hypertension
  • Market Restraints
    • Risks associated with negative impact on patients
  • Market Opportunities
    • Development and introduction of new therapies
    • Supportive government initiatives for healthcare drug manufacturing
  • Market Challenges
    • Strict regulations and compliance by regulatory bodies

Porter's Five Forces: A Strategic Tool for Navigating the Diuretics Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diuretics Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diuretics Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diuretics Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diuretics Drugs Market

A detailed market share analysis in the Diuretics Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diuretics Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diuretics Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diuretics Drugs Market

A strategic analysis of the Diuretics Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diuretics Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amneal Pharmaceuticals LLC, Centaur Pharmaceuticals Pvt Ltd, Hikma Pharmaceuticals Inc., Merck & Co., Inc., Novartis International AG, Perrigo Pharmaceuticals Company, Sanofi S.A., and Zydus Lifesciences Limited.

Market Segmentation & Coverage

This research report categorizes the Diuretics Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Type, market is studied across Calcium Sparing Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Low Ceiling Diuretics, Osmotic Diuretics, Potassium-Sparing Diuretics, and Thiazide Diuretics Local.
  • Based on Distribution Channel, market is studied across Drug Stores, Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Route of Administration, market is studied across Intravenous and Oral.
  • Based on Applications, market is studied across Diabetes Insipidus, Edema, Hypercalciuria, and Hypertension.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of renal and kidney disorders
      • 5.1.1.2. Growing geriatric populace globally
      • 5.1.1.3. Increasing adoption to treat high blood pressure and hypertension
    • 5.1.2. Restraints
      • 5.1.2.1. Risks associated with negative impact on patients
    • 5.1.3. Opportunities
      • 5.1.3.1. Development and introduction of new therapies
      • 5.1.3.2. Supportive government initiatives for healthcare drug manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations and compliance by regulatory bodies
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diuretics Drugs Market, by Drug Type

  • 6.1. Introduction
  • 6.2. Calcium Sparing Diuretics
  • 6.3. Carbonic Anhydrase Inhibitors
  • 6.4. Loop Diuretics
  • 6.5. Low Ceiling Diuretics
  • 6.6. Osmotic Diuretics
  • 6.7. Potassium-Sparing Diuretics
  • 6.8. Thiazide Diuretics Local

7. Diuretics Drugs Market, by Distribution Channel

  • 7.1. Introduction
  • 7.2. Drug Stores
  • 7.3. Hospital Pharmacies
  • 7.4. Online Pharmacies
  • 7.5. Retail Pharmacies

8. Diuretics Drugs Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intravenous
  • 8.3. Oral

9. Diuretics Drugs Market, by Applications

  • 9.1. Introduction
  • 9.2. Diabetes Insipidus
  • 9.3. Edema
  • 9.4. Hypercalciuria
  • 9.5. Hypertension

10. Americas Diuretics Drugs Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Diuretics Drugs Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Diuretics Drugs Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amneal Pharmaceuticals LLC
  • 3. Centaur Pharmaceuticals Pvt Ltd
  • 4. Hikma Pharmaceuticals Inc.
  • 5. Merck & Co., Inc.
  • 6. Novartis International AG
  • 7. Perrigo Pharmaceuticals Company
  • 8. Sanofi S.A.
  • 9. Zydus Lifesciences Limited

LIST OF FIGURES

  • FIGURE 1. DIURETICS DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. DIURETICS DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. DIURETICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. DIURETICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIURETICS DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIURETICS DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIURETICS DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIURETICS DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CALCIUM SPARING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIURETICS DRUGS MARKET SIZE, BY CARBONIC ANHYDRASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LOOP DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIURETICS DRUGS MARKET SIZE, BY LOW CEILING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIURETICS DRUGS MARKET SIZE, BY OSMOTIC DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIURETICS DRUGS MARKET SIZE, BY POTASSIUM-SPARING DIURETICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIURETICS DRUGS MARKET SIZE, BY THIAZIDE DIURETICS LOCAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL DIURETICS DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL DIURETICS DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL DIURETICS DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL DIURETICS DRUGS MARKET SIZE, BY DIABETES INSIPIDUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL DIURETICS DRUGS MARKET SIZE, BY EDEMA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HYPERCALCIURIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL DIURETICS DRUGS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 41. CANADA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 45. MEXICO DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 49. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES DIURETICS DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 63. CHINA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 67. INDIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 71. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 75. JAPAN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 79. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 87. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 95. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 99. THAILAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 103. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA DIURETICS DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 112. DENMARK DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 116. EGYPT DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 120. FINLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 124. FRANCE DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 128. GERMANY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 132. ISRAEL DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 136. ITALY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 140. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 144. NIGERIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 148. NORWAY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 152. POLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 156. QATAR DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 160. RUSSIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 164. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 168. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 172. SPAIN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 176. SWEDEN DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 180. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 184. TURKEY DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM DIURETICS DRUGS MARKET SIZE, BY APPLICATIONS, 2018-2030 (USD MILLION)
  • TABLE 196. DIURETICS DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 197. DIURETICS DRUGS MARKET, FPNV POSITIONING MATRIX, 2023